Back to Search
Start Over
Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance.
- Source :
-
Cancer science [Cancer Sci] 2012 Jan; Vol. 103 (1), pp. 88-99. Date of Electronic Publication: 2011 Nov 07. - Publication Year :
- 2012
-
Abstract
- Alcoholic extract of Piper betle (Piper betle L.) leaves was recently found to induce apoptosis of CML cells expressing wild type and mutated Bcr-Abl with imatinib resistance phenotype. Hydroxy-chavicol (HCH), a constituent of the alcoholic extract of Piper betle leaves, was evaluated for anti-CML activity. Here, we report that HCH and its analogues induce killing of primary cells in CML patients and leukemic cell lines expressing wild type and mutated Bcr-Abl, including the T315I mutation, with minimal toxicity to normal human peripheral blood mononuclear cells. HCH causes early but transient increase of mitochondria-derived reactive oxygen species. Reactive oxygen species-dependent persistent activation of JNK leads to an increase in endothelial nitric oxide synthase-mediated nitric oxide generation. This causes loss of mitochondrial membrane potential, release of cytochrome c from mitochondria, cleavage of caspase 9, 3 and poly-adenosine diphosphate-ribose polymerase leading to apoptosis. One HCH analogue was also effective in vivo in SCID mice against grafts expressing the T315I mutation, although to a lesser extent than grafts expressing wild type Bcr-Abl, without showing significant bodyweight loss. Our data describe the role of JNK-dependent endothelial nitric oxide synthase-mediated nitric oxide for anti-CML activity of HCH and this molecule merits further testing in pre-clinical and clinical settings.<br /> (© 2011 Japanese Cancer Association.)
- Subjects :
- Animals
Antineoplastic Agents pharmacology
Benzamides
Blotting, Western
Eugenol chemistry
Eugenol pharmacology
Flow Cytometry
Fusion Proteins, bcr-abl genetics
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology
Leukocytes, Mononuclear drug effects
Leukocytes, Mononuclear metabolism
Male
Membrane Potential, Mitochondrial drug effects
Mice
Mice, Nude
Mice, SCID
Mitochondria metabolism
Nitric Oxide metabolism
Phosphorylation drug effects
Piperazines pharmacology
Plant Extracts pharmacology
Plant Leaves chemistry
Pyrimidines pharmacology
Tumor Cells, Cultured
Apoptosis drug effects
Drug Resistance, Neoplasm drug effects
Eugenol analogs & derivatives
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
MAP Kinase Kinase 4 metabolism
Mitochondria drug effects
Nitric Oxide Synthase Type III metabolism
Piper betle chemistry
Reactive Oxygen Species metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1349-7006
- Volume :
- 103
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Cancer science
- Publication Type :
- Academic Journal
- Accession number :
- 21943109
- Full Text :
- https://doi.org/10.1111/j.1349-7006.2011.02107.x